Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Enliven Therapeutics, Inc. | 20,491 | reported | 06 Feb 2025 | tx 4+88,257 |
| OnKure Therapeutics, Inc. | 7,650 | reported | 28 May 2025 | tx 2+22,950 |
| MoonLake Immunotherapeutics | 6,682 | reported | 05 Jun 2025 | tx 4+70,667 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Jun 2025 | GRANT_AWARD | MoonLake Immunotherapeutics | 6,682 | 0.00 USD | deriv |
| 28 May 2025 | GRANT_AWARD | OnKure Therapeutics, Inc. | 7,650 | 0.00 USD | deriv |
| 06 Feb 2025 | GRANT_AWARD | Enliven Therapeutics, Inc. | 20,491 | 0.00 USD | deriv |
| 04 Oct 2024 | GRANT_AWARD | OnKure Therapeutics, Inc. | 15,300 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | MoonLake Immunotherapeutics | 7,688 | 0.00 USD | deriv |
| 13 Feb 2024 | GRANT_AWARD | Enliven Therapeutics, Inc. | 16,835 | 0.00 USD | deriv |
| 08 Jun 2023 | GRANT_AWARD | MoonLake Immunotherapeutics | 11,297 | 0.00 USD | deriv |
| 23 Feb 2023 | GRANT_AWARD | Enliven Therapeutics, Inc. | 27,567 | 0.00 USD | deriv |
| 06 Apr 2022 | GRANT_AWARD | MoonLake Immunotherapeutics | 45,000 | 0.00 USD | deriv |